Oncology Case Reports: Immune-Related and Treatment-Induced Complications in Clinical Practice

Deadline for manuscript submissions: 19 Oct 2026 | Viewed by 1050
Impact Factor: 3.899 | Citiescore: 2.5

Special Issue Editors

Ian James Martins
Centre of Excellence for Alzheimer’s Disease Research and Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup WA 6027, Australia.,7103152779
Interests: Molecular and metabolic mechanisms of diabetes and insulin resistance, nutrition and metabolism, proteomics and lipidomics, atherosclerosis, myocardial infarction, neurodegenerative diseases (Alzheimer’s), apoptosis, translational and systems-level approaches to disease progression and diagnostics.

fellow.iasr@gmail.com

Special Issue Information

Dear Colleagues,

Oncology practice increasingly encounters complex immune-related and treatment-induced complications that significantly affect patient outcomes, quality of life, and clinical decision-making. With the expanding use of immunotherapies, targeted agents, and multimodal treatment strategies, clinicians face evolving challenges in early recognition, accurate diagnosis, and effective management of these complications in real-world settings.

Despite growing awareness, there remains variability in how such adverse events are identified, reported, and managed across clinical practice. There is a pressing need to consolidate clinical experience and evidence to better guide practitioners in addressing these complications promptly and effectively.

I am pleased to invite you to contribute to a Special Issue of Current Oncology entitled “Oncology Case Reports: Immune-Related and Treatment-Induced Complications in Clinical Practice.” This Special Issue aims to highlight clinically significant case reports and case series that provide valuable insights into the diagnosis, management, and outcomes of therapy-related complications.

This Special Issue will bring together high-quality case-based evidence and expert perspectives that enhance our understanding of adverse events associated with cancer therapies, particularly in the context of emerging treatments and personalized oncology care.

We welcome submissions including, but not limited to, the following areas:

  • Immune-related adverse events associated with immunotherapy; 
  • Treatment-induced toxicities from chemotherapy, radiotherapy, and targeted therapies; 
  • Rare or atypical clinical presentations and diagnostic challenges; 
  • Multisystem complications and their management strategies; 
  • Case-based insights into early detection and intervention; 
  • Supportive care approaches in managing therapy-related complications; 
  • Real-world clinical experiences and lessons learned. 

If you are interested in contributing, I would be happy to discuss potential case topics or abstracts with you.

I look forward to the possibility of receiving your valuable contribution.

Dr. Charos Dimitrios
Guest Editor

 

Manuscript Submission Information

Manuscripts should be submitted through the online submission system of Auctores Publishing LLC by registering and logging in on the journal’s website. Once registered, authors can proceed to the submission portal and follow the step-by-step instructions to upload their manuscript and associated files. Submissions are accepted until the specified deadline for the Special Issue.

All submitted manuscripts that successfully pass the initial editorial assessment will undergo a rigorous peer-review process. Accepted articles will be published online promptly and made available as part of the Special Issue collection. We welcome original research articles, review articles, and case reports/short communications relevant to the scope of the issue. For planned submissions, authors may send a proposed title and a short abstract (approximately 200–250 words) to the Editorial Office for preliminary evaluation.

Submitted manuscripts must be original, not previously published, and not under consideration for publication elsewhere (except for conference abstracts or proceedings, where applicable). All manuscripts are reviewed through a single-blind peer-review process, ensuring high academic and ethical standards.

Detailed guidelines regarding manuscript preparation, formatting, and submission requirements are available on the Instructions for Authors page of the respective journal under Auctores Publishing LLC. Authors are strongly encouraged to review these guidelines prior to submission.

Auctores journals are international, peer-reviewed, open access publications, ensuring wide dissemination and accessibility of published research. An Article Processing Charge (APC) may apply upon acceptance of the manuscript; authors will be informed of the applicable fee during the submission or acceptance process.

Manuscripts should be written in clear, concise English and adhere to high academic standards. Authors who require assistance with language editing are encouraged to use professional English editing services prior to submission or during the revision process.

Keywords

  • Immune-related adverse events
  • Treatment-induced complications
  • Oncology case reports
  • Immunotherapy toxicity
  • Chemotherapy side effects
  • Targeted therapy complications
  • Cancer treatment toxicity management
  • Immune checkpoint inhibitors

Benefits

Ease of Navigation:
Organizing articles within a Special Issue around a focused theme enables readers and researchers to efficiently explore relevant content within a broad-scope journal.

Enhanced Visibility and Discoverability:
Special Issues increase the reach and impact of published research by bringing together related work in one place, making articles more accessible and more likely to be read and cited.

Strengthening Research Networks:
Special Issues foster collaboration by connecting researchers, clinicians, and experts working within similar domains, encouraging knowledge exchange and future partnerships.

Wider Promotion and Outreach:
Articles published in Special Issues are actively promoted through the journal’s digital platforms, newsletters, and academic networks, improving visibility among the global research community.

Archiving and Collection Opportunities:
Selected Special Issues may be curated and archived as thematic collections, providing long-term accessibility and recognition for contributing authors.

Published Papers

Coming Soon

Dear Editorial Team, Clinical Medical Reviews and Reports. My experience with the journal was highly positive. The peer-review process was rigorous, constructive, and completed in a timely manner. The reviewers provided valuable comments that helped improve the quality and clarity of our manuscript. The editorial office was professional, responsive, and supportive throughout all stages of the publication process. Communication was clear and efficient, and any questions were addressed promptly. Overall, I found the journal to maintain high scientific standards and an excellent publication workflow. I would be pleased to consider submitting future work to this journal. Best wishes from, Elena Popa.

img

Dr Elena Popa

It was my pleasure to submit my testimonial concerning the Reviewer Board of our Scientific Journal “Brain and Neurological Disorders”. The Reviewers focused on some modifications and their contribution was helpful. The ladies of our Editorial Office were also supported my efforts. It was my honor to have such a co-operation and I am looking forward for more collaboration.

img

Dr Nikolaos Andreas Chrysanthakopoulos

Dear Grace Pierce, Editorial Coordinator of Journal of Clinical Research and Reports, Thank you for the speedy and efficient peer review process. I appreciate the fact that your peer reviewers do not take months to respond like with some other journals. I would also like to thank the editorial office for responding quickly to my questions. It is an excellent journal. I plan to submit more manuscripts in the future. Best wishes from, Robert W. McGee

img

Robert W McGee

Dear Grace Pierce, Editorial Coordinator of Journal of Clinical Research and Reports, Working with you and your team on our recent publication in JCRR has been a truly wonderful and enjoyable experience. The responses were prompt, and the reviewers were patient, constructive, and highly professional. One reviewer in particular gave me the feeling that a professor was carefully reading and commenting on my coursework, which was deeply touching. The entire process was straightforward and hassle‑free, with no tedious online forms to complete. I highly recommend this journal. Best wishes from, DR Aibing Rao, Head of R&D

img

Aibing Rao

I Appreciate the Opportunity to Share my Experience with the Journal of Clinical Research and Reports. The peer review process was timely and constructive, and the feedback provided helped improve the quality of our manuscript. The editorial office was professional, responsive, and supportive throughout the process, ensuring smooth communication and efficient handling of the submission. Overall, it was a positive experience collaborating with your team.

img

Kashani Mehdi

Dear Mercy Grace, Editorial Coordinator of Obstetrics Gynecology and Reproductive Sciences, We would like to express our gratitude for your help at all stages of publishing and editing the article. The editors of the magazine answer all the necessary questions and help at every stage. We will definitely continue to cooperate and publish other works in the Obstetrics Gynecology and Reproductive Sciences! Best wishes from, Alla Konstantinovna Politova,

img

Alla Konstantinovna Politova